Laure Deyme

4PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 18, 2024
Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Primary Results From AMEERA-5.

Javier Cortés, Sara A Hurvitz, Joyce O'Shaughnessy

|Apr 29, 2021
Population pharmacokinetic model of irinotecan and its four main metabolites in patients treated with FOLFIRI or FOLFIRINOX regimen.

Laure Deyme, Dominique Barbolosi, Litaty Céphanoée Mbatchi

|Nov 18, 2018
Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters.

Laure Deyme, Dominique Barbolosi, Florence Gattacceca

Pageof 1